JMP Securities reiterated their market outperform rating on shares of Altimmune (NASDAQ:ALT – Get Rating) in a report released on Friday, Benzinga reports. They currently have a $15.00 target price on the stock. Several other research analysts have also weighed in on the stock. Evercore ISI upped their price objective on shares of Altimmune from […]
Altimmune, Inc. (NASDAQ:ALT – Get Rating) insider Matthew Scott Harris bought 10,000 shares of the stock in a transaction on Thursday, March 23rd. The shares were acquired at an average cost of $4.22 per share, for a total transaction of $42,200.00. Following the purchase, the insider now owns 33,311 shares in the company, valued at […]
The Goldman Sachs Group cut shares of Altimmune (NASDAQ:ALT – Get Rating) from a buy rating to a neutral rating in a research report report published on Tuesday, MarketBeat reports. The brokerage currently has $6.00 price objective on the stock, down from their prior price objective of $20.00. A number of other equities research analysts […]
Altimmune, Inc. (NASDAQ:ALT) Shares Purchased by Goldman Sachs Group Inc. etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.